Utah Medical Products
UTMD
63 hedge funds and large institutions have $125M invested in Utah Medical Products in 2014 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 15 reducing their positions, and 6 closing their positions.
67% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 6
67% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 15
7% more funds holding
Funds holding: 59 → 63 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less capital invested
Capital invested by funds: $138M → $125M (-$13.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
American Century Companies
Kansas City,
Missouri
|
+$2M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.63M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$630K |
| 4 |
MDCM
Morgan Dempsey Capital Management
Menomonee Falls,
Wisconsin
|
+$484K |
| 5 |
CYG
Clean Yield Group
Norwich,
Vermont
|
+$476K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bares Capital Management
Austin,
Texas
|
-$4.53M |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$283K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$211K |
| 4 |
CIS
Connors Investor Services
Wyomissing,
Pennsylvania
|
-$208K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$101K |
UTMD Hedge Fund Activity: Q2 2014 in Review
63 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q2 2014, worth a combined $125M — down 9.8% from $138M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new UTMD positions and 6 closed out — a net gain of 4 holders — while 25 added to existing stakes and 15 trimmed.
The largest buyer was American Century Companies, adding an estimated $2M. The largest seller was Bares Capital Management, cutting an estimated $4.53M.
- 63 institutional investors held Utah Medical Products (UTMD) as of Q2 2014, up from 59 in Q1 2014.
- Funds reported $125M of Utah Medical Products stock for Q2 2014, down 9.8% quarter-over-quarter.
- 10 funds opened new Utah Medical Products positions in Q2 2014 and 6 closed out, a net change of +4 holders.
- The largest Utah Medical Products buyer in Q2 2014 was American Century Companies, an estimated $2M added.
- The largest Utah Medical Products seller in Q2 2014 was Bares Capital Management, an estimated $4.53M sold.
Based on aggregated 13F filings for Q2 2014.